Anthony S. Gibney - 16 May 2025 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Reporting relationship: Chief Financial and Business Officer
Issuer ticker: AURA
Reported as of: 16 May 2025
Net transaction value: +$237,177
SEC form: 4
Accepted by SEC: 20 May 2025, 17:34:24 UTC
Prior SEC filing: 16 May 2025
Next SEC filing: 04 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Conor Kilroy, as Attorney-in-Fact

Key filing fact

Anthony S. Gibney filed Form 4 for Aura Biosciences, Inc. (AURA) on 20 May 2025.

Key facts

This page summarizes Anthony S. Gibney's Form 4 filing for Aura Biosciences, Inc. (AURA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 May 2025, 17:34.

Change

Previous filing in this sequence was filed on 16 May 2025.
Current net transaction value: +$237,177.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001750132 Primary reporting owner

Gibney Anthony S

Relationship: Chief Financial and Business Officer
Address: C/O AURA BIOSCIENCES, INC., 80 GUEST STREET, BOSTON
Signature: /s/ Conor Kilroy, as Attorney-in-Fact
Signature date: 20 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AURA transaction

Common Stock

Purchase

Transaction value: $245,000
Shares: +50,000
Change %: +592%
Price: $4.90
Shares after: 58,452
Date: 16 May 2025
Ownership: Direct
Footnotes: F1

AURA transaction

Common Stock

Sale

Transaction value: $7,823
Shares: -1,519
Change %: -2.6%
Price: $5.15
Shares after: 56,933
Date: 16 May 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AURA transaction Derivative

Common Stock Warrants (right to buy)

Purchase

Transaction value
Shares: +12,500
Change %
Price
Shares after: 12,500
Date: 16 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price: $4.90
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering.

Footnote F2

The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

SEC remarks

Chief Financial and Business Officer